Randomized controlled trials are also needed to determine whether statins can actually reduce the risk for hepatocellular ...

Statin use in patients with chronic liver disease was associated with a reduced risk of hepatocellular carcinoma (HCC) and hepatic decompensation, researchers found. In a cohort of 16,501 individuals ...

The tryptophan pathway makes tryptophan, the cholesterol pathway makes cholesterol, and neither pathway makes side products. How has such perfection come about? Presumably, evolution—successive ...

More Americans than ever are taking statins. But just because you’re eligible, does that mean you should take one? The quick and short answer is, yes! If diet and exercise aren’t enough ...

Atherosclerotic cardiovascular disease (ASCVD) remains the leading cause of morbidity and mortality worldwide. Cardiovascular (CV) risk reduction is important in patients at high risk for a first ...